相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolyl Carboxypeptidase Activity Decline Correlates with Severity and Short-Term Outcome in Acute Ischemic Stroke
Kaat Kehoe et al.
NEUROCHEMICAL RESEARCH (2015)
Effect of Dipeptidyl Peptidase 4 Inhibition on Arterial Blood Pressure is Context Dependent
Edwin K. Jackson et al.
HYPERTENSION (2015)
Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells
Diana Roehrborn et al.
FEBS LETTERS (2014)
Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice
Dong Yang et al.
BRAIN RESEARCH (2013)
The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain A Comparison With Glimepiride
Vladimer Darsalia et al.
DIABETES (2013)
DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
Richard P. Shannon
DIABETES (2013)
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
M. Monami et al.
DIABETES OBESITY & METABOLISM (2013)
Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors
Veerle Matheeussen et al.
CLINICA CHIMICA ACTA (2012)
Fibroblast Activation Protein in Remodeling Tissues
M. Jacob et al.
CURRENT MOLECULAR MEDICINE (2012)
Permeating the Blood Brain Barrier and Abrogating the Inflammation in Stroke: Implications for Stroke Therapy
Cesar V. Borlongan et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN- like proteases in cerebral ischemia
Peter Roehnert et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
Veerle Matheeussen et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke
Natalia S. Rost et al.
STROKE (2012)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata
Chad E. Brokopp et al.
EUROPEAN HEART JOURNAL (2011)
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α
Fiona M. Keane et al.
FEBS JOURNAL (2011)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome
R. Brouns et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Clinical, Biochemical and Neuroimaging Parameters after Thrombolytic Therapy Predict Long-Term Stroke Outcome
Raf Brouns et al.
EUROPEAN NEUROLOGY (2009)
Blood glucose in acute stroke
Tom Skyhoj Olsen
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Dimethylarginine Levels in Cerebrospinal Fluid of Hyperacute Ischemic Stroke Patients are Associated with Stroke Severity
Raf Brouns et al.
NEUROCHEMICAL RESEARCH (2009)
Clinical Evidence That Very Small Embryonic-Like Stem Cells Are Mobilized Into Peripheral Blood in Patients After Stroke
Edyta Paczkowska et al.
STROKE (2009)
Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA
Raf Brouns et al.
CLINICA CHIMICA ACTA (2008)
Stromal cell-derived factor 1 alpha mediates neural progenitor cell motility after focal cerebral ischemia
AM Robin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Progressing stroke: Towards an internationally agreed definition
P Birschel et al.
CEREBROVASCULAR DISEASES (2004)
Characterization of blood-brain barrier permeability to PYY3-36 in the mouse
N Nonaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
分享论文
